ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
0.14%
US Tech 100
17,618.80
0.05%
S&P 500
5,187.70
0.13%
US Dollar vs CAD
1.37536
0.15%
Bitcoin
62,539.64
0.33%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biodexa Pharmaceuticals PLC (BDRX)

  7. Biodexa Pharmaceuticals PLC (BDRX) News

BDRX Biodexa Pharmaceuticals PLC

1.0345
-0.0755 (-6.80%)
May 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Biodexa Pharmaceuticals PLC BDRX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0755 -6.80% 1.0345 18:55:16
Open Price Low Price High Price Close Price Previous Close
1.08 0.988 1.09 1.00 1.11
more quote information »

Recent News

Date Time Source Heading
4/30/202410:51GLOBEBiodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial..
4/26/202407:30GLOBEBiodexa Enters Into Exclusive License to eRapa™, a Phase 3..
4/19/202407:00GLOBEPreliminary Results for the Year Ended 31 December 2023
2/23/202407:30GLOBEBiodexa Announces Positive Top Line Phase I Clinical Trial..
2/13/202407:15APSBiotech Shares Bid Up Premarket Following 9.9% Institutional..
2/08/202407:30GLOBEBiodexa Reports 12 Month Survival in MAGIC-G1 Study of..
2/07/202407:30GLOBEBiodexa Announces Allowance of U.S. Patent Covering..
1/22/202407:30GLOBEBiodexa CEO Issues Shareholder Letter Highlighting Progress..
12/29/202303:05GLOBEBiodexa Appoints Ann Merchant to the Board of Directors
12/21/202315:00GLOBEBiodexa Announces Closing Of $6.0 Million Underwritten..
12/19/202307:42GLOBEBiodexa Announces Pricing of $5.2 Million Underwritten..
11/27/202308:00GLOBEBiodexa Enters Into Agreements to Acquire Exclusive..
10/03/202307:30GLOBEBiodexa Completes Recruitment of Cohort A in Study of MTX110..
9/29/202315:30GLOBEInterim results for the six months ended 30 June 2023
9/21/202307:30GLOBEBiodexa to Present Recruitment and Treatment Update in ..
7/28/202307:00GLOBEBiodexa Pharmaceuticals Launches New Corporate and Clinical..
7/24/202306:30GLOBEBiodexa Regain Compliance with NASDAQ Minimum Bid Price..
7/10/202307:00GLOBECompletion of Enrolment and Treatment in the Phase 1 Study..
7/06/202315:30GLOBEResults of Appeal of Delisting Determination
7/06/202307:15GLOBEPublication of Manuscript from the PNOC015 (a.k.a. MTD-201)..
6/22/202315:15GLOBEADR Ratio Change
6/20/202307:00GLOBEAppeal of Delisting Determination
6/15/202315:05GLOBEReceipt of NASDAQ Delisting Determination Plans to Appeal
6/14/202307:30GLOBEResults of Annual General Meeting and General Meeting
5/26/202315:05GLOBEBiodexa Pharmaceuticals PLC Announces Closing of $3.32..
5/24/202307:40GLOBEBiodexa Pharmaceuticals PLC Announces US$3.32 Million..
5/22/202315:15GLOBEPosting of Annual Report & Notice of AGM
5/18/202307:30GLOBEBiodexa Pharmaceuticals Enters into Non-binding Letter of..

Your Recent History

NASDAQ
BDRX
Biodexa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved